November 27 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Friday that its profit before taxes rose by an annual 15% to 20.2 million levs ($12.3 million/10.3 million euro) in the January-October period of 2020.
Sopharma Trading's sales revenue increased by 12% year-on-year to 715.5 million levs in the first ten months of 2020, the drug trader said in a bourse filing.
In October alone, the company's profit before taxes grew 21% to 2.2 million levs backed by a 13% increase in sales, to 76.5 million levs.
As at 11:50 CET on Friday, Sopharma Trading shares traded 1.68% lower at 5.85 levs on the Bulgarian Stock Exchange.
Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)